Table 1

Baseline characteristics of HIV+ WIHS participants who are not ART naïve

VariablesN (%) or mean ± SD
Indices
FFI
 0–2 points1143 (82.5)
 3–5 points242 (17.5)
VACS Index score
 0–164 points28.9±19.4
CES-D score >16 points
 No844 (60.9)
 Yes541 (39.1)
Outcomes
All deaths
 3 years or less73 (5.3)
 >3–8 years111 (8.0)
AIDS deaths*
 3 years or less39 (2.8)
 >3–8 years35 (2.5)
Non-AIDS deaths*
 3 years or less32 (2.3)
 >3–8 years45 (3.2)
HIV variables
CD4 count (cells/mm3)
 >500554 (40.0)
 200–499614 (44.3)
 <200217 (15.7)
Viral load (copies/mL)
 <500820 (59.2)
 500–100 000510 (36.8)
 >100 00055 (4.0)
Haemoglobin (g/dL)
 >14209 (15.1)
 12–13.9743 (53.6)
 10–11.9362 (26.1)
 <1071 (5.1)
FIB4
 <1.451018 (73.5)
 1.45–3.25280 (20.2)
 >3.2587 (6.3)
eGFR (mL/min)
 >601277 (92.2)
 45–59.971 (5.1)
 30–44.915 (1.1)
 <3022 (1.6)
 Hepatitis C coinfection298 (21.5)
Demographic variables
 Average age (years, mean ± SD)42.6±8.8
Race/ethnicity
 White324 (23.4)
 Black806 (58.2)
 Others255 (18.4)
Education
 <High school536 (38.7)
>High school847 (61.2)
 Mission2 (0.1)
Smoking history
 Not current smoking786 (56.8)
 Current smoking599 (43.2)
Income
 <$12 000669 (48.3)
>$12 000668 (48.2)
 Missing48 (3.5)
Current alcohol drinking
 Abstainer/none743 (53.6)
 Low490 (35.4)
 Moderate129 (9.3)
 High23 (1.7)
BMI, kg/m2
 BMI<30916 (66.1)
 BMI>30 (obesity)461 (33.3)
 Missing8 (0.6)
Current ART use
 No400 (28.9)
 Yes (HAART)984 (71.0)
 Missing1 (0.1)
Prior AIDS-defining illness
 No802 (57.9)
 Yes583 (42.1)
Injection drug use ever
 Yes305 (22.0)
 No1071 (77.3)
 Missing9 (0.6)
Prior pneumonia
 No1080 (78.0)
 Yes305 (22.0)
Current/prior hypertension
 No964 (69.6)
 Yes421 (30.4)
History of diabetes
 No1195 (86.3)
 Yes190 (13.7)
Prior cancer diagnosis
 No1220 (88.1)
 Yes165 (11.9)
  • *For some deaths, cause of death could not be classified as AIDS/non-AIDS, thus the numbers of AIDS + non-AIDS deaths do not sum to total deaths.

  • ART, antiretroviral therapies; BMI, body mass index; CES-D, Center for Epidemiologic Studies-Depression; eGFR, estimated glomerular filtration rate; FFI, Fried Frailty Index; HAART, highly active antiretroviral therapy; HIV+, HIV-infected; VACS, Veterans Aging Cohort Study; WIHS, Women’s Interagency HIV Study.